Gids voor de samenleving

WHO Guidance on AI in Health

WHO guidance on AI in health emphasizes human rights, safety, transparency, accountability, inclusion, and ongoing evaluation.

  • 3 minuten lezen
  • Laatst bijgewerkt
Op deze pagina3 minuten lezen
  1. Overzicht
  2. Diepe duik
  3. Strategische impact
  4. The Future of WHO Guidance on AI in Health
  5. Implementatie in de echte wereld
  6. Risico's en vangrails
  7. Implementatie routekaart
  8. Blijf verkennen
  9. Veelgestelde vragen

Overzicht

These are governance principles, not a product certification or a substitute for local law. Health systems should involve affected people, assess risks through the lifecycle, and ensure that AI supports rather than displaces human decision-making.

Diepe duik

The World Health Organization’s guidance on ethics and governance of AI for health sets out principles for designing, developing, and using AI in ways that protect people and public interests. Its framework calls for human autonomy, safety and well-being, transparency, responsibility and accountability, inclusion and equity, and responsiveness and sustainability. These principles apply across the lifecycle, from deciding whether AI is appropriate to monitoring how it works in practice. WHO emphasizes that people should remain in control of healthcare systems and medical decisions, and that privacy and confidentiality should be protected. AI should be developed for well-defined use cases, with quality controls and meaningful information about design and limitations. Organizations should establish mechanisms for questioning decisions and redress when people are harmed. Inclusion requires attention to who benefits, who is left out, and how access is distributed. The guidance is normative and does not certify a product or replace national regulation. Health systems can use it to build governance: define accountability, engage patients and health workers, assess bias and safety, protect data, and monitor real-world use. WHO’s later guidance on large multimodal models applies similar principles to generative AI, urging careful evaluation and human oversight. Governance should be adapted to local law and health-system capacity. Consider procurement, workforce effects, and how patients can opt out or ask questions. Assign responsibility for responding when a system behaves unexpectedly.

Strategische impact

Risico en veiligheid

Catastrofale en alledaagse schade door AI hangt af van wie de risico's begrijpt en wie kan handelen.

Duidelijkere beslissingen

Publieke en professionele geletterdheid bepalen of een krachtig veiligheidsbeleid politiek mogelijk is.

Door de hype heen snijden

Duidelijke verklaringen verminderen de kans op hypes, laboratorium-PR en vaag ethisch theater.

The Future of WHO Guidance on AI in Health

WHO and national bodies continue to develop guidance as new AI capabilities enter health systems. More capable generative models increase the importance of measuring benefit before routine use and maintaining privacy, accountability, and human oversight. Health organizations can build trust through transparent limits, community participation, and continuous evaluation. Ethical governance is an ongoing responsibility shared by developers, providers, governments, and affected people. Evidence of benefit and harm should inform revisions. Include feedback from affected communities and evaluate outcomes after system changes.

Implementatie in de echte wereld

A health ministry includes clinicians and patient groups in AI governance planning.

A hospital establishes a way to report and investigate algorithm-related harm.

A developer documents data limits and evaluates performance in intended settings.

A public agency checks whether AI access benefits groups equitably.

Risico's en vangrails

  • Existentieel risico behandelen als sciencefiction, terwijl capaciteiten zich vermenigvuldigen.

  • De veiligheid van oppervlakteproducten verwarren met uitlijning onder hoge autonomie.

  • Hierdoor blijven niet-Engelstalige en niet-deskundige doelgroepen alleen bronnen van lage kwaliteit over.

Implementatie routekaart

  1. Afzonderlijke risico's voor productschade, misbruik en verlies van controle/verkeerde uitlijning.

  2. Vraag welk bewijs uw kijk op tijdlijnen en ernst zou veranderen.

  3. Geef de voorkeur aan primaire bronnen en concrete evaluaties boven marketingclaims.

  4. Identificeer één actiepad: carrière, beleid, financiering of vaardigheden – niet alleen bewustwording.

Blijf verkennen

Free newsletter

Get the daily AI briefing

Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.

One email each weekday. Unsubscribe in one click. We never sell or share your address.

Test yourself

Take the WHO Guidance on AI in Health quiz

Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.

Quiz starten

Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation

Veelgestelde vragen

What is WHO Guidance on AI in Health?

WHO guidance on AI in health emphasizes human rights, safety, transparency, accountability, inclusion, and ongoing evaluation. These are governance principles, not a product certification or a substitute for local law. Health systems should involve affected people, assess risks through the lifecycle, and ensure that AI supports rather than displaces human decision-making.

What does WHO’s AI-in-health guidance provide?

WHO guidance sets principles and recommendations, not product certification.

Is WHO guidance a product certification?

The guide distinguishes ethical principles from legal authorization.

Which disclosure most directly explains a health AI tool’s intended use, evidence, and limitations?

Transparency should help people understand the system and its use.

Who shares responsibility for ethical AI in health?

WHO frames governance as a shared stakeholder responsibility.